BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36782075)

  • 1. Diagnostic and prognostic biomarkers reflective of cardiac remodelling in diabetes mellitus: A scoping review.
    Chhor M; Law W; Pavlovic M; Aksentijevic D; McGrath K; McClements L
    Diabet Med; 2023 May; 40(5):e15064. PubMed ID: 36782075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Thresholds for Pre-Diabetes Mellitus and Diabetes Mellitus and Subclinical Cardiac Disease in the General Population:
    Myhre PL; Lyngbakken MN; Berge T; Røysland R; Aagaard EN; Pervez O; Kvisvik B; Brynildsen J; Norseth J; Tveit A; Steine K; Omland T; Røsjø H
    J Am Heart Assoc; 2021 Jun; 10(11):e020447. PubMed ID: 33998259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
    Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
    Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
    Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study.
    Ravassa S; Kuznetsova T; Varo N; Thijs L; Delles C; Dominiczak A; Díez J; Staessen JA
    Int J Cardiol; 2015 Apr; 185():177-85. PubMed ID: 25796005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
    Srivatsan V; George M; Shanmugam E
    Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.
    De Marco C; Claggett BL; de Denus S; Zile MR; Huynh T; Desai AS; Sirois MG; Solomon SD; Pitt B; Rouleau JL; Pfeffer MA; O'Meara E
    ESC Heart Fail; 2021 Apr; 8(2):1130-1138. PubMed ID: 33438360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Mueller L; Koch C; Mayr A; Theurl M; Kirchmair R; Klug G; Metzler B
    Heart; 2017 Jun; 103(11):856-862. PubMed ID: 27979879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Cardiovascular Toxicities Induced by Cancer Therapies and Promising Biomarkers for Their Prediction: A Scoping Review.
    Yan T; Yu H; Li T; Dong Y
    Heart Lung Circ; 2024 May; 33(5):605-638. PubMed ID: 38242833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Scoping Review of Galectin-3 as a Biomarker of Cardiovascular Diseases in Pediatric Populations.
    Smereczyńska-Wierzbicka E; Pietrzak R; Werner B
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
    Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
    Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SALIVA-based diagnostic approach for diabetes mellitus: a step towards non-invasive detection - a scoping review.
    Cenzato N; Cazzaniga F; Maspero C; Tartaglia GM; Del Fabbro M
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12080-12087. PubMed ID: 38164870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediterranean Diet and Its Association with Cardiovascular Disease Risk Factors: A Scoping Review.
    Richardson LA; Izuora K; Basu A
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.